|[July 10, 2014]
UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014
NEW YORK --(Business Wire)--
Levi & Korsinsky announces that a class action lawsuit has been
commenced in the United States District Court for the District of
Arizona on behalf of investors who purchased INSYS Therapeutics, Inc.
("INSYS" or the "Company") (Nasdaq:INSY) securities between May 1, 2013
and May 8, 2014.
For more information, click here: http://zlkdocs.com/INSY-Info-Request-Form-1970.
The complaint alleges that the Company made false and/or misleading
statements and/or faile to disclose that: (a) the Company had engaged
in illegal and/or unethical off-label marketing of its drug Subsys; (b)
the Company was exposed to potential fines and other disciplinary
actions as a result of said marketing practices; and (c) as a result,
the Company's financial statements were materially false and misleading
at all relevant times.
If you suffered a loss in INSYS you have until July 14, 2014 to request
that the Court appoint you as lead plaintiff. Your ability to share in
any recovery doesn't require that you serve as a lead plaintiff. To
obtain additional information, contact Joseph E. Levi, Esq. either via
email at email@example.com or by
telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlkdocs.com/INSY-Info-Request-Form-1970.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut, and Washington D.C. The firm's 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior results
do not guarantee similar outcomes.
[ Back To Technology News's Homepage ]